Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion

Not Applicable

• Conditions: Abortion, Missed
• Interventions: Device: Karman curettage

• Registration Number: NCT02917785
• Lead Sponsor: Meir Medical Center

Brief Summary

the purpose of this study is to examine the success rates of Karman curettage in completing the abortion after failed recurred treatment with Misoprostol for women with missed abortion.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2016-09
• Study First Submitted: 2016-09-07
• Study First Submitted QC: 2016-09-26
• Study First Posted: 2016-09-28
• Study Start: 2016-10
• Last Update Submitted: 2016-11-23
• Last Update Posted: 2016-11-25
• Primary Completion: 2017-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Healthy women diagnosed with missed abortion treated in Meir Medical Center.
• The abortion occured during the first trimester of pregnancy.
• Patients who chose drug therapy (Misoprostol), after retained products of conception were evident on ultrasound.

Read More

Exclusion Criteria

• patients with mullarian abnormality (i.e. septal uterus, myoma etc.)
• patients with significant bleeding
• Endometrial wall (residua) greater than 20 mm.
• known or suspected infection
• known clotting defect
• women after cesarean section
• closed cervix

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Karman curettage	Karman curettage	after a retained product of interception is observed in ultrasound examination, the women in this arm will undergo Karman curretage.

Primary Outcome Measures

Name	Time	Method
Completing the abortion	1 month	completing the abortion until the scheduled day for hysteroscopy, thus preventing the need for hysteroscopy

Secondary Outcome Measures

Name	Time	Method
number of days of bleeding	3 months	asking the patient how many days of bleeding did she have after the procedure
Pain intensity	3 months	asking the patient about the intensity of the pain during and after the procedure, as measured with NRS-11 pain scale
infection	3 months	asking the patient if she was diagnosed with any infection signs
number of sick days	3 months	asking the patients how many sick leave days did she take
number of days of abstinence from sexual intercourse	3 months	asking the patient how many days did she abstain from sexual intercourse after the procedure
pregnancy	3 months	asking the patient if she is currently pregnant

Trial Locations

Locations (1)

Meir Medical center; 🇮🇱 Kfar Saba, Israel